title: Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
abstract: OBJECTIVE
  Many studies have shown that an increased nuchal translucency (NT) may be a good marker of fetal heart malformation, but the extent to which NT is suitable for identifying the population at risk remains unclear. We aimed to determine the value of NT measurement and of the presence of cystic hygroma colli in the screening of euploid fetuses for congenital heart defects (CHD).
  
  
  METHODS
  We carried out a retrospective analysis of 12 910 euploid pregnancies examined between January 1995 and August 2007 at our institution. The screening performance of NT measurements in identifying fetuses with CHD was assessed, with comparison between the use of cut-offs defined as absolute values, multiples of the median (MoM) and percentiles. The presence of cystic hygroma colli was also assessed in the prediction of CHD.
  
  
  RESULTS
  The incidence of major CHD was 3.4 per thousand (44/12 910). The sensitivity of NT measurement in screening for major CHD was 54.5% if the threshold was set at the 95(th) percentile, 45.4% if it was set at 3 mm, 27.3% for 3.5 mm, 50.0% for 1.5 MoM and 45.5% for 1.75 MoM. The false-positive rates for these thresholds were 8.4, 6.6, 1.7, 8.9 and 6.3%, respectively. The incidence of major CHD was 1.2% (10/813) in cases of thick NT (> 95(th) centile) and 4.3% (13/304) in cases of hygroma colli.
  
  
  CONCLUSIONS
  NT measurement during the first trimester is potentially useful for screening for fetal major CHD. Screening performance is consistent whether NT values are expressed as MoMs, percentiles or absolute values. The incidence of major CHD seems to be higher in cases of cystic hygroma colli.
authors.affiliation: Department of Ultrasound and Fetal Medicine, CMCO-SIHCUS, Strasbourg, France.
authors.forename: N
authors.initials: N
authors.lastname: Sananes
authors.forename: V
authors.initials: V
authors.lastname: Guigue
authors.forename: M
authors.initials: M
authors.lastname: Kohler
authors.forename: N
authors.initials: N
authors.lastname: Bouffet
authors.forename: M
authors.initials: M
authors.lastname: Cancellier
authors.forename: F
authors.initials: F
authors.lastname: Hornecker
authors.forename: M C
authors.initials: MC
authors.lastname: Hunsinger
authors.forename: A
authors.initials: A
authors.lastname: Kohler
authors.forename: C
authors.initials: C
authors.lastname: Mager
authors.forename: M
authors.initials: M
authors.lastname: Neumann
authors.forename: E
authors.initials: E
authors.lastname: Schmerber
authors.forename: M
authors.initials: M
authors.lastname: Tanghe
authors.forename: I
authors.initials: I
authors.lastname: Nisand
authors.forename: R
authors.initials: R
authors.lastname: Favre
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D005318:Fetal Heart / Q000002:abnormalities / Q000000981:diagnostic imaging*; D005865:Gestational Age; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging* / Q000196:embryology / Q000235:genetics; D006801:Humans; D015994:Incidence; D018191:Lymphangioma, Cystic / Q000000981:diagnostic imaging* / Q000196:embryology / Q000235:genetics; D008875:Middle Aged; D048208:Nuchal Translucency Measurement; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016216:Ultrasonography, Prenatal; D055815:Young Adult